LAG3 and neoplasm: Using a different tumor model of colon cancer, MC38, we expand on their data by showing the efficacy of AU-011 and ICI on distant tumors and identify the combination with anti-PD-L1 and anti-LAG-3 as the most suitable treatment regimen for both primary and distant tumors.